Covaxin has overall vaccine efficacy of 77.8%, claims Bharat Biotech in results from Phase 3 trials

Covaxin has overall vaccine efficacy of 77.8%, claims Bharat Biotech in results from Phase 3 trials

6:11 PM
Covaxin showed 65.2% protection against the Delta variant (B.1.617.2) of COVID-19. 

from Zee News :India National https://ift.tt/3yhEwmL
via
Next
« Prev Post
Previous
Next Post »

Subscribe to: Post Comments (Atom)